Poster presentation with the Alzstatin platform now available on AlzeCure's website
AlzeCure Pharma AB (publ) (FN STO: ALZCUR) (“AlzeCure”), a pharmaceutical company that develops a broad portfolio of drug candidates for diseases affecting the central nervous system, with projects in both Alzheimer’s disease and pain, today announced that the company's poster presentation and abstract about the Alzstatin platform, which was presented at the annual Alzheimer's conference CTAD, Clinical Trials in Alzheimer's Disease, on November 4-7, 2020, are now available in full on the company's website.The poster presentation, given by Johan Sandin, CSO at AlzeCure, presents how the